Concepedia

Robert Murdoch

RM

Statistics

Publications

25

Citations

878

H-Index

19

Active since

1986

Affiliations

GlaxoSmithKline (United Kingdom)(Current)

University of Manchester

Centre Hospitalier Universitaire de Saint-Pierre

Age UK

Wiltshire and Swindon History Centre

Robert Murdoch is an author at GlaxoSmithKline (United Kingdom) specializing in pharmacology, medicine, and immunology.

Publications per year

1986–2017

25

Publications

25

Transient receptor potential vanilloid 1 (TRPV1) antagonism in patients with refractory chronic cough: A double-blind randomized controlled trial

Saifudin Khalid, Robert Murdoch, Amy Newlands et al. · Journal of Allergy and Clinical Immunology · 2014 · 187 citations · Full text

, , +10

(Imidazo[1,2-a]pyrimidin-2-yl)phenylmethanones and related compounds as potential nonsedative anxiolytics

S. Clements-Jewery, G. W. DANSWAN, Colin Gardner et al. · Journal of Medicinal Chemistry · 1988 · 79 citations

, , +7

Inhaled LPS induces blood release of Clara cell specific protein (CC16) in human beings

Olivier Michel, Robert Murdoch, Alfred Bernard · Journal of Allergy and Clinical Immunology · 2005 · 51 citations

, , +9

The effects of a TRPV1 antagonist, SB-705498, in the treatment of seasonal allergic rhinitis

Philippe Bareille, Robert Murdoch, Jane Denyer et al. · International Journal of Clinical Pharmacology and Therapeutics · 2013 · 42 citations

, , +17

Effects of a novel sodium channel blocker, GSK2339345, in patients with refractory chronic cough

John A. Smith, Lorcan McGarvey, Huda Badri et al. · International Journal of Clinical Pharmacology and Therapeutics · 2017 · 38 citations

, , +15

1–5 of 25